» Articles » PMID: 31118417

The K219T-Lamin Mutation Induces Conduction Defects Through Epigenetic Inhibition of SCN5A in Human Cardiac Laminopathy

Abstract

Mutations in LMNA, which encodes the nuclear proteins Lamin A/C, can cause cardiomyopathy and conduction disorders. Here, we employ induced pluripotent stem cells (iPSCs) generated from human cells carrying heterozygous K219T mutation on LMNA to develop a disease model. Cardiomyocytes differentiated from these iPSCs, and which thus carry K219T-LMNA, have altered action potential, reduced peak sodium current and diminished conduction velocity. Moreover, they have significantly downregulated Na1.5 channel expression and increased binding of Lamin A/C to the promoter of SCN5A, the channel's gene. Coherently, binding of the Polycomb Repressive Complex 2 (PRC2) protein SUZ12 and deposition of the repressive histone mark H3K27me3 are increased at SCN5A. CRISPR/Cas9-mediated correction of the mutation re-establishes sodium current density and SCN5A expression. Thus, K219T-LMNA cooperates with PRC2 in downregulating SCN5A, leading to decreased sodium current density and slower conduction velocity. This mechanism may underlie the conduction abnormalities associated with LMNA-cardiomyopathy.

Citing Articles

Perinuclear organelle trauma at the nexus of cardiomyopathy pathogenesis arising from loss of function mutation.

Choi J Nucleus. 2025; 16(1):2449500.

PMID: 39789731 PMC: 11730615. DOI: 10.1080/19491034.2024.2449500.


Disorganized chromatin hierarchy and stem cell aging in a male patient of atypical laminopathy-based progeria mandibuloacral dysplasia type A.

Jin W, Jiang S, Liu X, He Y, Li T, Ma J Nat Commun. 2024; 15(1):10046.

PMID: 39567511 PMC: 11579472. DOI: 10.1038/s41467-024-54338-3.


Cardiomyopathy: pathogenesis and therapeutic interventions.

Huang S, Li J, Li Q, Wang Q, Zhou X, Chen J MedComm (2020). 2024; 5(11):e772.

PMID: 39465141 PMC: 11502724. DOI: 10.1002/mco2.772.


Past Trends and Future Directions of Cardiac Regenerative Medicine - A Systematic Analysis of Clinical Trial Registries.

Wulfse M, Vervoorn M, Amelink J, Ballan E, de Jager S, Sluijter J J Cardiovasc Transl Res. 2024; 18(1):209-220.

PMID: 39361114 PMC: 11885401. DOI: 10.1007/s12265-024-10563-1.


LAP2alpha facilitates myogenic gene expression by preventing nucleoplasmic lamin A/C from spreading to active chromatin regions.

Ferraioli S, Sarigol F, Prakash C, Filipczak D, Foisner R, Naetar N Nucleic Acids Res. 2024; 52(19):11500-11518.

PMID: 39228367 PMC: 11514464. DOI: 10.1093/nar/gkae752.


References
1.
Zhang J, Wilson G, Soerens A, Koonce C, Yu J, Palecek S . Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res. 2009; 104(4):e30-41. PMC: 2741334. DOI: 10.1161/CIRCRESAHA.108.192237. View

2.
Lodola F, Morone D, Denegri M, Bongianino R, Nakahama H, Rutigliano L . Adeno-associated virus-mediated CASQ2 delivery rescues phenotypic alterations in a patient-specific model of recessive catecholaminergic polymorphic ventricular tachycardia. Cell Death Dis. 2016; 7(10):e2393. PMC: 5133973. DOI: 10.1038/cddis.2016.304. View

3.
Luperchio T, Wong X, Reddy K . Genome regulation at the peripheral zone: lamina associated domains in development and disease. Curr Opin Genet Dev. 2014; 25:50-61. DOI: 10.1016/j.gde.2013.11.021. View

4.
van Berlo J, de Voogt W, van der Kooi A, van Tintelen J, Bonne G, Ben Yaou R . Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death?. J Mol Med (Berl). 2004; 83(1):79-83. DOI: 10.1007/s00109-004-0589-1. View

5.
Zhang H, Kieckhaefer J, Cao K . Mouse models of laminopathies. Aging Cell. 2012; 12(1):2-10. DOI: 10.1111/acel.12021. View